John  Hernandez net worth and biography

John Hernandez Biography and Net Worth

Director of ResMed

John Hernandez has served as a ResMed director since November 2021, and is a member of the compliance oversight committee.

Dr. Hernandez is head of clinical research, health economics, and outcomes research at Google (NASDAQ: GOOGL). He joined Alphabet in 2016 where he has built and led teams at Verily and Google leveraging artificial intelligence to assist in promoting healthy lifestyles, diagnosing cancer, preventing blindness, and more.

Dr. Hernandez is a medical device and digital health executive with over 30 years of experience in clinical research, health economics, market access, and global commercial strategy. Prior to joining Alphabet, he was vice president of global health economics and outcomes research at Abbott Laboratories (NYSE: ABT), and vice president of health economics and clinical research at Boston Scientific Corporation (NYSE: BSX). He has also been an adjunct faculty member at Stanford University and served in health services research, strategy consulting, and health policy roles at the RAND Corporation, Quintiles, PwC, and the American Society of Internal Medicine (now ACP).

Dr. Hernandez is widely published in scientific journals and is a frequent healthcare lecturer. He holds a Ph.D. and master’s in health policy from the RAND Graduate School in Santa Monica, California, and a bachelor’s in political science from the University of North Carolina at Chapel Hill.

What is John Hernandez's net worth?

The estimated net worth of John Hernandez is at least $1.02 million as of August 18th, 2025. Hernandez owns 4,045 shares of ResMed stock worth more than $1,017,115 as of December 4th. This net worth estimate does not reflect any other assets that Hernandez may own. Learn More about John Hernandez's net worth.

How do I contact John Hernandez?

The corporate mailing address for Hernandez and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on John Hernandez's contact information.

Has John Hernandez been buying or selling shares of ResMed?

John Hernandez has not been actively trading shares of ResMed in the last ninety days. Most recently, John Hernandez sold 2,575 shares of the business's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $287.10, for a transaction totalling $739,282.50. Following the completion of the sale, the director now directly owns 4,045 shares of the company's stock, valued at $1,161,319.50. Learn More on John Hernandez's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Jan De Witte (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), John Hernandez (Director), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 28 times. They sold a total of 113,322 shares worth more than $27,967,228.39. The most recent insider tranaction occured on December, 3rd when Director Peter C Farrell sold 2,000 shares worth more than $502,940.00. Insiders at ResMed own 0.7% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 12/3/2025.

John Hernandez Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2025Sell2,575$287.10$739,282.504,045View SEC Filing Icon  
See Full Table

John Hernandez Buying and Selling Activity at ResMed

This chart shows John Hernandez's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $251.45
Low: $250.34
High: $252.75

50 Day Range

MA: $259.74
Low: $243.91
High: $283.40

2 Week Range

Now: $251.45
Low: $199.92
High: $293.81

Volume

486,714 shs

Average Volume

1,048,878 shs

Market Capitalization

$36.70 billion

P/E Ratio

25.74

Dividend Yield

0.95%

Beta

0.87